Nalaganje...
Beta-lactamase inhibitors from laboratory to clinic.
beta-Lactamases constitute the major defense mechanism of pathogenic bacteria against beta-lactam antibiotics. When the beta-lactam ring of this antibiotic class is hydrolyzed, antimicrobial activity is destroyed. Although beta-lactamases have been identified with clinical failures for over 40 years...
Shranjeno v:
| izdano v: | Clin Microbiol Rev |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1988
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC358033/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3060240/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cmr.1.1.109 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|